skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

When it comes to value frameworks, one thing is certain, they’re here to stay.


Payers are tightening their grip on the rising cost of specialty drugs, and are increasingly using value frameworks to tie drug price to value. For pharma, value frameworks can be just as useful in assessing the value of therapies and getting a clear view of the relative value of your drug against the competition.

In a landscape that continues to shift, existing frameworks are evolving and new frameworks are emerging.

Download your free market access article pack on value frameworks and find out:


  • What value tools exist today, what’s coming soon, and who’s behind them?
  • How they’re shaping discussions on price vs. value?
  • How evolving frameworks stand to impact your market access potential?


Download now


Read also

  • Scrip: industry news and insights

    Ready, Set, Lowest: Who Won China's Latest Drug Bidding War?

    By Brian Yang

    Multinationals are feeling the heat to win in China's latest drug procurement battle. The winning prices have surprised even previous winners and may have a profound and long-lasting impact on the pharma sector.

    Topics Deal trends Strategy

  • Awareness

    MS Outlook 2020 Scrip 100

    Outlook 2020 is the annual look at the performance and future prospects of the global pharmaceutical industry. This year, the supplement will reach more people than ever before with distribution to In Vivo, Pink Sheet, Scrip, Medtech Insight and Generics bulletin subscribers PLUS events such as Biotech Showcase and Partnerships in Clinical Trials.

    Topics Deal trends BioPharmaceutical Business strategies

  • Pink Sheet: global policy and regulatory coverage

    The Drug Pricing Article Pack

    Get expert insights into the events driving drug pricing polices around the world.  This Article Pack covers drug pricing issues for: The EU - Vital developments for Norway, Denmark, and other EU countries, including the UK The US – Essential drug pricing info from a country where the issue has taken center stage Australia – Developments surrounding drug pricing issues in Australia

    Topics Deal trends Policy and regulation


Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: